Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

LTIP Awards

7 Nov 2008 08:00

RNS Number : 6817H
ABCAM Plc
07 November 2008
 



For immediate release

7 November 2008

ABCAM PLC

("Abcam" or "the Company")

Long-Term Incentive Plan

Abcam plc announces that on 6 November 2008 the Remuneration Committee granted the following conditional nil cost share awards to the Executive Directors of the Company under the Abcam plc Long-Term Incentive Plan (the "LTIP") approved by shareholders at the Company's AGM on 3 November 2008.

In accordance with the rules of the LTIP, LTIP awards were granted on 6 November 2008 at a price of £4.62 per ordinary share (the closing share price on 5 November 2008) as follows:

Number of Ordinary Shares subject to the

LTIP Award

Jonathan Milner

45,454

Jim Warwick

37,878

Jeff Iliffe

33,333

The shares subject to the LTIP awards will be released in three years' time subject to continued employment and subject to the satisfaction of certain specific performance conditions based on:

the Company's Comparative Total Shareholder Return ("TSR") performance against a Comparator Group of companies; and 

growth in Earnings per Share.

For further information please contact: 

Abcam

+ 44 (0) 1223 696000

Jeff Iliffe, Chief Financial Officer

Numis Securities

+ 44 (0) 207 260 1000

Nominated Adviser: Nick Westlake, Michael Meade

Corporate Broking: James Black

Buchanan Communications

+ 44 (0) 20 7466 5000

Mark Court / Mary-Jane Johnson / Stasa Filiplic

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBRBFTMMBMMRP
Date   Source Headline
1st Oct 20204:41 pmRNSTotal Voting Rights
25th Sep 20201:33 pmRNSDirector/PDMR Shareholding
18th Sep 20202:19 pmRNSBlock listing Interim Review
18th Sep 20207:54 amRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSFull Year Results 2020
11th Sep 202010:34 amRNSNotice of Results
1st Sep 20207:52 amRNSTotal Voting Rights
4th Aug 202012:57 pmRNSTotal Voting Rights
23rd Jul 20207:00 amRNSChange of Adviser
23rd Jul 20207:00 amRNSFull Year Trading Update
2nd Jul 202010:11 amRNSTotal Voting Rights
16th Jun 202012:00 pmRNSDirectorate Change
1st Jun 20209:29 amRNSTotal Voting Rights
11th May 202011:00 amRNSStatement re Update on 2019 AGM Resolution Vote
1st May 202012:24 pmRNSTotal Voting Rights
22nd Apr 202010:11 amRNSHolding(s) in Company
21st Apr 20207:26 amRNSDirector/PDMR Shareholding
20th Apr 202010:19 amRNSHolding(s) in Company
20th Apr 20207:00 amRNSCOVID-19 Update
14th Apr 202010:07 amRNSHolding(s) in Company
9th Apr 20205:33 pmRNSIssue of Shares
2nd Apr 20209:50 amRNSTotal Voting Rights
27th Mar 20203:37 pmRNSHolding(s) in Company
9th Mar 20207:00 amRNSInterim results for 6 months ended 31 Dec 2019
4th Mar 20207:00 amRNSAcquisition of Marker Gene Technologies
2nd Mar 20203:43 pmRNSTotal Voting Rights
2nd Mar 20208:00 amRNSBlock listing Interim Review
4th Feb 202010:49 amRNSTotal Voting Rights
30th Jan 20207:00 amRNSAbcam expands cell engineering capabilities
28th Jan 20202:31 pmRNSHolding(s) in Company
28th Jan 20202:29 pmRNSDirector/PDMR Shareholding
14th Jan 20207:00 amRNSAppointment of Chief Financial Officer
10th Jan 20207:00 amRNSHalf Year Trading Update
2nd Jan 20209:45 amRNSTotal Voting Rights
2nd Jan 20207:00 amRNSTransaction complete between Abcam and Expedeon
19th Dec 201910:05 amRNSHolding(s) in Company
4th Dec 20193:37 pmRNSHolding(s) in Company
2nd Dec 20193:25 pmRNSDirector/PDMR Shareholding
2nd Dec 20199:30 amRNSTotal Voting Rights
21st Nov 201911:42 amRNSHolding(s) in Company
14th Nov 20197:00 amRNSAbcam Capital Markets Event
13th Nov 20194:45 pmRNSResult of AGM
11th Nov 20197:00 amRNSAbcam to acquire proteomics & immunology business
6th Nov 20199:06 amRNSDirector/PDMR Shareholding
1st Nov 201910:55 amRNSTotal Voting Rights
2nd Oct 20194:28 pmRNSHolding(s) in Company
2nd Oct 20191:49 pmRNSDirector/PDMR Shareholding
1st Oct 20192:22 pmRNSTotal Voting Rights
30th Sep 20191:35 pmRNSAnnual Financial Report
26th Sep 20192:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.